🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr Chinmayi A showing data from Myriad Genetics on ancestry-based differences in VUS findings in >80k patients with #ovariancancer. We need to include more diverse women in genetic testing and only make recs for pathogenic variants! #SGO2025 Team Ovary, Memorial Sloan Kettering Cancer Center Sutter Health Kaiser Permanente

Exciting data presented by Jamie Bakkum-Gamez for a novel tampon-based screening test for #EndometrialCancer! Could have implications for those at high genetic risk and #lynchsyndrome CGA-IGC MSKCC Team Uterus

My amazing colleague #RachelGrisham bringing novel therapies to rare cancer types! Avutometinib + Defactinib shows promise in mesonephric tumors and is moving to 2nd stage. Great moderating by Róisín O’Cearbhaill #SGO2025. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus MSK Department of Medicine Memorial Sloan Kettering Cancer Center

Our amazing fellow #clarissalam looked at role of pre-operative imaging in #endometrialcancer and found that symptoms/physical exam were critical in low grade EC but that imaging found disease in asymptomatic patients with high grade EC MSKCC Team Uterus

Help prevent “missed opportunities” in #ovariancancer Sara Moufarrij found 15-23% of patients w/ HGSOC had a surgery where opportunistic salpingectomy (OS) was missed. Kara Long & others are raising awareness. We need data to guide patients! Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Thanks #ProfMichaelSeckl from Imperial College London & #charingcross who shared his expertise on #gestationaltrophoblasticneoplasm (GTN) and the promise of immunotherapy! #raretumors Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus Memorial Sloan Kettering Cancer Center MSK Department of Medicine

MUTYH: Possibly another important gene in ovarian cancer? sciencedirect.com/science/articl…. Studies are small and more work needs to be done. Thanks #melissafrey for letting me join this work! Team Ovary, Memorial Sloan Kettering Cancer Center

Please join us for Memorial Sloan Kettering Cancer Center’s 14th Annual Lynch Syndrome Educational Workshop 🗓️ Tues, May 6 ⌚️6-8:30 PM 📍Zoom Register: bit.ly/3EsxdBp CGA-IGC Fight Colorectal Cancer AliveAndKickn Global Colon Cancer Association Colorectal Cancer Alliance Colon Cancer Foundation Colon Cancer Coalition InSiGHT NSGC CancerSIG

Great collaboration with #JohnChan Sutter Health using Myriad Genetics registry data! Rates of germline mutations in uterine cancer were high (14.6%) & varied by ancestry. This large database of >35k pts verified our MSKCC Team Uterus data. sciencedirect.com/science/articl…

Although we will miss her Memorial Sloan Kettering Cancer Center and in our GMO group, there are only congratulations for Claire Friedman MD as she embarks on the next phase of her career! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center MSK Department of Medicine

Congrats to Mark G. Kris, Kenneth Offit, David G. Pfister, and Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 on being inducted into the 13th Giants of Cancer Care® class by OncLive.com! This award honors leading physicians who are advancing #cancerresearch. Memorial Sloan Kettering Cancer Center Learn more: bit.ly/42Ox58M

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

We were so fortunate to have a fantastic discussion with world-renowned expert Dr. Pei Hui MD PhD regarding diagnosis and management of gestational trophoblastic neoplasia as part of our departmental lecture series program. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Congratulations to Kenneth Offit, MD, MPH of Memorial Sloan Kettering Cancer Center in being the Giants of Cancer Care Prevention/Genetics inductee! #GiantsCC25

Read more about research from Alicia Latham, MD,MS aimed to investigate the potential of Pap-derived #ctDNA (Pap-ctDNA) as a novel noninvasive tool for EC detection from ASCO. #ASCO25

So proud of Weill Cornell Medicine resident #judywang for her hard work characterizing the germline landscape of early-onset #endometrialcancer! It is unique and needs attention #ASCO25 MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center MSK Department of Medicine Memorial Sloan Kettering Cancer Center

Check out Ariadna Roqué Lloveras and her awesome #ASCO25 poster building on work from Team Ovary, Memorial Sloan Kettering Cancer Center looking at #breastcancer after #ovariancancer in this with germline mutations in non-BRCA HR genes, shockingly none! Memorial Sloan Kettering Cancer Center MSK Department of Medicine

Promising combo of Pembro + Olaparib in p53 aberrant/CN-H #endometrialcancer presented by Maria Rubinstein, MD at #ASCO25! We need more biomarkers to find those long term responders. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center MSK Department of Medicine

So proud of Sara Moufarrij who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center MSK Department of Medicine

In 2024, led by our immediate past president Bryson Katona, MD, PhD, the #CGAIGC Executive Council developed a 3-year strategic plan to guide our society's future ➡️We’re proud to share this roadmap as we mark #CGAIGC’s 30th anniversary and its publication in FamilialCancer!